Aquaphilus dolomiae extract counteracts the effects of cutaneous S. aureus secretome isolated from atopic children on CD4+ T cell activation

Hélène Martin, Emeline Laborel-Préneron, Frédérique Fraysse, Thien Nguyen, Anne-Marie Schmitt, Daniel Redoulès & Christian Davrinche

Pharmaceutical Biology

2016

Atopic dermatitis is an inflammatory condition that typically results in dry skin and itching.

A cellular study was published in 2016 in the Pharmaceutical Biology journal, led by Dr. Christian Davrinche, INSERM Research Director at the Pathophysiology Center of Toulouse Purpan Hospital and an expert in immunology.

This cellular study showed that I-modulia®, the aqueous extract of Aquaphilus dolomiae contained in XeraCalm A.D, has immunosuppressive properties due to its ability to stimulate production of anti-inflammatory IL-10 in cases of atopic dermatitis.

Psoriasis
Pruritus
Eczema
Seborrheic dermatitis

Development and preliminary validation of the patientreported “Chronic Itch Burden Scale”, assessing healthrelated quality of life in chronic pruritus

DUCRAY

J. Theunis, C. Nordon iD , B. Falissard, M. Orri, V. Mengeaud, L. Misery

British Journal of Dermatology

2021

View publication

Publication Summary

Aquaphilus dolomiae extract counteracts the effects of cutaneous S. aureus secretome isolated from atopic children on CD4+ T cell activation

Our other publications on this subject

Want to read on?

Want to read on?